Sign Up to like & get
recommendations!
0
Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.836.836
Abstract: Introduction. Bortezomib (Bort) and lenalidomide (Len) are standard treatments for relapsed MM, but, so far, a comparative trial between them has never been conducted. We designed a multicenter, open label, phase III study to compare…
read more here.
Keywords:
rcd arms;
cyclophosphamide dexamethasone;
vcd rcd;
bort len ... See more keywords